AstraZeneca PLC
AZN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $203,112,000 | $210,401,400 | $209,908,800 | $165,197,000 |
| - Cash | $5,488,000 | $5,840,000 | $6,166,000 | $6,329,000 |
| + Debt | $30,114,000 | $28,622,000 | $29,143,000 | $30,688,000 |
| Enterprise Value | $227,738,000 | $233,183,400 | $232,885,800 | $189,556,000 |
| Revenue | $54,073,000 | $45,811,000 | $44,351,000 | $37,417,000 |
| % Growth | 18% | 3.3% | 18.5% | – |
| Gross Profit | $43,866,000 | $37,543,000 | $31,960,000 | $24,980,000 |
| % Margin | 81.1% | 82% | 72.1% | 66.8% |
| EBITDA | $15,438,000 | $13,422,000 | $9,085,000 | $5,113,000 |
| % Margin | 28.6% | 29.3% | 20.5% | 13.7% |
| Net Income | $7,035,000 | $5,955,000 | $3,288,000 | $112,000 |
| % Margin | 13% | 13% | 7.4% | 0.3% |
| EPS Diluted | 1.13 | 1.91 | 1.06 | 0.04 |
| % Growth | -40.8% | 80.2% | 2,550% | – |
| Operating Cash Flow | $11,861,000 | $10,345,000 | $9,808,000 | $5,963,000 |
| Capital Expenditures | -$4,586,000 | -$3,778,000 | -$2,571,000 | -$2,200,000 |
| Free Cash Flow | $7,275,000 | $6,567,000 | $7,237,000 | $3,763,000 |